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In Utero Drug Exposure Impact on Infant Health
By: Katie Edwards, Lisa Borges, Carlie Schoenherr

Literature Review #1

Literature Review #2

Recommendations for practice change
Purpose: The purpose of this study was to examine the
consequences and risk factors of opioid drug use during
pregnancy on the baby. The research question was “What are
the prenatal risk factors and perinatal and postnatal outcomes
associated with maternal opioid use during pregnancy?”
Design: Cohort study of urban, low income, multiethnic
mother-infant pairs.
Sample: 8,905 urban, low-income, and multiethnic motherinfant pairs at Boston Medical Center. The sample was also
limited to mothers giving birth to a single infant and having a
live birth.
Reliability and validity of information: The study used the
mother’s and infant’s electronic medical record (EMR)
measure the outcomes. The article does not specifically state
the validity or reliability of the EMR. One can assume the
patient’s EMR is both valid and reliable because it is
considered to be a legal document.
Results: The main results of this study were in utero opioid
exposure is associated with preterm birth, higher risk of fetal
growth restriction, and lack of physiological development.
This study found that prenatal opioid exposure led to an
increased risk of perinatal and postnatal health outcomes.
Conclusion: This study shows that there is significant evidence
that in utero exposure to drugs impacts the infant's health.This
study also shows in utero drug exposure impacts the infant’s
development.

Azuine, R., Ji, Y., & Chang, H.-Y. (2019). Prenatal Risk Factors and Perinatal and Postnatal
Outcomes Associated With Maternal Opioid Exposure in an Urban, Low-Income, Multiethnic
US Population. Jama Network Open, 2(6). doi: 10.1001/jamanetworkopen.2019.6405

The current practice should be changed to educate mothers about the
risks of using drugs during pregnancy and the effects it can have on
their child. Education should begin when women reach childbearing
age. Preventative education is important because once the mother
conceives a baby it is too late, the baby has already been exposed to
the drugs. Further research needs to be done to find effective
interventions to help mothers cease their drug use.

PICOT Question
In newborns, what is the effect of drug use by the expecting
mother in comparison to no drug use by the expecting mother in
the baby’s first year of life?

Why is this a problem?
Drug exposure in utero poses a significant threat to the infant’s
health compared to no drug exposure. These health impacts not
only affect the infant at birth but as the child ages. Some of these
risks include preterm birth, low birth weight, neurocognitive,
and physical development problems.

Clinical Significance
Research shows that in utero drug exposure increases health risks for
the infant. Interventions need to be implemented to decrease the
number of expecting mothers who use drugs. It is important for
healthcare providers to acknowledge all substances that may put the
fetus at harm. The results from this research can be used to help
healthcare providers educate their patients on the importance of
abstaining from these harmful substances.

Purpose: The purpose of this study was to determine the
relationship between prenatal opioid exposure and the
cognitive and motor development of that child.
Design: Retrospective cohort study- Two exposure groups:
prenatal opioid exposure and no prenatal opioid exposure.
Sample: In this sample of 26 studies, 1,455 children who
had prenatal opioid exposure were studied and compared to
2,982 children who did not have prenatal opioid exposure in
regards to their cognitive and motor development.
Reliability and validity of information: This article
was valid and reliable because it was completed by studying
26 other cohort studies done on the topic of opioid use during
pregnancy. It was also reliable and valid because they worked
hard not to have bias during the research and found very
educational articles.
Results: The primary outcome of the study indicated that
prenatal opioid exposure is negatively associated with
neurocognitive and physical development from the ages of 6
months until adolescence. Children that were exposed to
opioids prenatally had lower cognitive and motor scores than
those children who had not been exposed to opioids
prenatally. Prenatal opioid exposure has also been associated
with increases in the risk of perinatal problems, including
neonatal abstinence syndrome (NAS), prematurity, and low
birth weight.
Conclusion: This study shows there is significant evidence
that prenatal opioid exposure has negative effects on an
infant's health. This study also shows that prenatal opioid
exposure results in lower cognitive and motor development.
Yeoh, S.L., Eastwood, J., Wright, I. M., Morton, R., Melhuish, E., Ward, M., &
Oei, J. L. (2019). Cognitive and Motor Outcomes of Children With Prenatal
Opioid Exposure: A Systematic Review and Meta-analysis. JAMA Network Open,
2(7), e197025. https://doi:10.1001/jamanetworkopen.2019.7025

